United Kingdom may be days away from approving Pfizer's COVID-19 vaccine

United Kingdom may be days away from approving Pfizer's COVID-19 vaccine

Pfizer's coronavirus vaccine is expected to get approval in the United Kingdom by the end of this week, the Telegraph reports on Monday, citing unidentified government sources.

Meanwhile, in the U.S., authorities said the vaccination programme could start by Mid-December.

The US Food and Drug Administration (FDA) is not meeting until December 10, a factor that would push the vaccine rollout start date beyond the expected timeline in the UK.

The watchdog has already been formally asked to assess the vaccines, and will receive the full set of safety and efficacy data on Monday or Tuesday. "Every adult in the country could be vaccinated by April, according to draft plans".

Similarly, on November 18, Pfizer had said that final results from the late-stage trial of its coronavirus vaccine was found to be 95 per cent effective and had no serious side effects on older people.

The provisional schedule - which depends on the authorisation and arrival of millions of vaccines - sees care home residents and staff, NHS workers, and the elderly starting to receive jabs before Christmas, and a far wider roll-out in the new year. "We are heading in the right direction but there is still a long way to go", Health Secretary Matt Hancock said.

Bancel said that the price he quoted was a "fair price" and that the company was not interested in "maximum profit", according to the report on Sunday.

Up to 30,000 volunteers are being sought to administer the doses in England and Wales.

"That is likely to happen in the month of May or something like that based on our plans."He continued: "I really hope and look forward to seeing the level of the negative perception of the vaccine decrease and people's acceptance increases".

Because the Pfizer vaccine has to be stored in extremely cold temperatures, it is likely to be administered from these sites.

The company said it remains on track to manufacture 500 million to 1 billion doses globally in 2021. It followed positive results this month from a vaccine developed by Pfizer Inc. Both types of jab require two doses, 28 days apart.

Britain has ordered 40 million doses and expects to have 10 million doses, enough to protect 5 million people, available by the end of the year if regulators approve it. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines.

Related Articles